Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
This study aims to investigate the impact of platelet concentrate (PC) transfusions on endothelial function and the systemic inflammatory response in thrombopenic patients admitted to intensive care who require prophylactic platelet transfusions.
Endothelial function will be measured using a laser Doppler device coupled with an acetylcholine iontophoresis system that is applied to the skin.
Eligibility criteria
Qualifiers
Adult patient ≥ 18 years of age
Admitted to intensive care
Requires prophylactic platelet transfusion for thrombocytopenia
Enrolled in a social security program
Disqualifiers
Recent platelet or red blood cell transfusion (< 24 hours)
Need for urgent red blood cell transfusion due to active bleeding
Patient under guardianship or conservatorship
Significant peripheral edema
Trial design
Treatments tested in this trial
- Not listed
Trial groups
60 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov